Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Beginning Cash Balance (2011 - 2012)

Sanara MedTech posted quarterly Beginning Cash Balance of -$573900.0 for Q4 2012, down 57390100.0% year-on-year from N/an in Q1 2012, and down 11578.0% on a QoQ basis from $5000.0 in Q3 2012.

Sanara MedTech (SMTI) has 2 years of Beginning Cash Balance data on file, last reported at -$573900.0 in Q4 2012.

  • For the quarter ending Q4 2012, Beginning Cash Balance fell 57390100.0% year-over-year to -$573900.0; the trailing twelve-month figure through Dec 2025 stood at -$573900.0 (changed N/A YoY), and the FY2025 full-year result was $1.6 million, changed N/A from the prior year.
  • Beginning Cash Balance for Q4 2012 stood at -$573900.0, down from $5000.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $21200.0 in Q2 2012 and bottomed at -$573900.0 in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Sanara MedTech 203.69 Mn 190.09 Mn 25.87 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 -573,900.00
Dec 31, 2012 -573,900.00
Sep 30, 2012 5,000.00
Sep 30, 2012 5,000.00
Jun 30, 2012 21,200.00
Jun 30, 2012 21,200.00
Dec 31, 2011 1.00
Dec 31, 2011 1.00